8-K/A
Current Report
Avalo Therapeutics, Inc. Filed Acc 0001104659-16-087895
Executive or director change
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading a16-1185_18ka.htm…